Papillary RCC Subtype Not Predictive of Survival, Study Finds
Two subtypes of papillary RCC – type I and type II – have been previously described.
All articles by Susan Moench, PhD, PA-C
Can Measurements of Tumor Perfusion Predict Response to VEGFR-Targeted TKI Therapy in Metastatic RCC?
Arterial spin labeled (ASL) perfusion magnetic resonance imaging (MRI) is a non–contrast-based, noninvasive imaging modality that quantifies blood flow to tissue.
Patient-Specific Characteristics and Costs Related to Oral Targeted Therapy in Metastatic RCC
Age, marital status, and geographic location tended to influence use of oral anticancer therapy in older patients with metastatic RCC.
Understanding the Stigma Experienced by Patients With Prostate Cancer
Interview study reveals men’s perception and concerns related to their prostate cancer journey.
Radiologic PFS Benefit Observed for Addition of AKT Inhibitor to Abiraterone in Metastatic CRPC
Loss of the tumor suppressor PTEN, a negative prognostic factor in metastatic CRPC, is associated with dysregulation of the PI3K–AKT–mTOR pathway.
Risk Factors for Poor Prognosis in Patients With Cancer and COVID-19
Data from the CCC19 registry were evaluated to uncover risk factors associated with increased 30-day mortality in patients with cancer infected with COVID-19.
Racial/Ethnic Disparities in Access to Telehealth Visits: Results From the COVID-19 and Cancer Outcomes Study
Black and Hispanic patients were more likely to have COVID-19 but less likely to have an increase in telehealth visits.
MASCC Survey Identifies Research, Development Goals for Cancer Survivorship Care
A survey of MASCC clinician members identified 3 areas for further research and development to improve survivorship care plans for cancer survivors.
Restructured Process Overcomes Barriers to Prior Authorization for Proton Therapy
This study examined the impact of a restructured prior authorization process on the delivery of PBT at a proton therapy center.
Routine Use of Neoadjuvant Docetaxel Plus ADT Not Supported in Localized, High-Risk Prostate Cancer
Patients with localized prostate cancer characterized by high-risk features are at increased risk of a negative outcome following radical prostatectomy.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...